nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—NR3C1—polycystic ovary syndrome	0.818	1	CbGaD
Triamcinolone—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0131	0.19	CbGeAlD
Triamcinolone—NR3C1—urine—polycystic ovary syndrome	0.00632	0.0916	CbGeAlD
Triamcinolone—CYP3A4—urine—polycystic ovary syndrome	0.00478	0.0693	CbGeAlD
Triamcinolone—SERPINA6—pituitary gland—polycystic ovary syndrome	0.00309	0.0448	CbGeAlD
Triamcinolone—SERPINA6—adrenal gland—polycystic ovary syndrome	0.00276	0.04	CbGeAlD
Triamcinolone—SERPINA6—endocrine gland—polycystic ovary syndrome	0.00239	0.0347	CbGeAlD
Triamcinolone—NR3C1—embryo—polycystic ovary syndrome	0.00204	0.0296	CbGeAlD
Triamcinolone—PTGS2—embryo—polycystic ovary syndrome	0.00177	0.0256	CbGeAlD
Triamcinolone—BCHE—endometrium—polycystic ovary syndrome	0.00168	0.0243	CbGeAlD
Triamcinolone—NR3C1—adrenal cortex—polycystic ovary syndrome	0.00167	0.0243	CbGeAlD
Triamcinolone—BCHE—uterus—polycystic ovary syndrome	0.00155	0.0224	CbGeAlD
Triamcinolone—BCHE—pituitary gland—polycystic ovary syndrome	0.00152	0.022	CbGeAlD
Triamcinolone—BCHE—adipose tissue—polycystic ovary syndrome	0.00151	0.0219	CbGeAlD
Triamcinolone—NR3C1—endometrium—polycystic ovary syndrome	0.0015	0.0217	CbGeAlD
Triamcinolone—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00145	0.021	CbGeAlD
Triamcinolone—NR3C1—uterus—polycystic ovary syndrome	0.00138	0.02	CbGeAlD
Triamcinolone—BCHE—adrenal gland—polycystic ovary syndrome	0.00136	0.0197	CbGeAlD
Triamcinolone—NR3C1—pituitary gland—polycystic ovary syndrome	0.00135	0.0196	CbGeAlD
Triamcinolone—NR3C1—adipose tissue—polycystic ovary syndrome	0.00135	0.0195	CbGeAlD
Triamcinolone—PTGS2—endometrium—polycystic ovary syndrome	0.00129	0.0188	CbGeAlD
Triamcinolone—BCHE—vagina—polycystic ovary syndrome	0.00126	0.0182	CbGeAlD
Triamcinolone—NR3C1—adrenal gland—polycystic ovary syndrome	0.00121	0.0175	CbGeAlD
Triamcinolone—PTGS2—uterus—polycystic ovary syndrome	0.00119	0.0173	CbGeAlD
Triamcinolone—BCHE—endocrine gland—polycystic ovary syndrome	0.00118	0.0171	CbGeAlD
Triamcinolone—PTGS2—pituitary gland—polycystic ovary syndrome	0.00117	0.017	CbGeAlD
Triamcinolone—PTGS2—adipose tissue—polycystic ovary syndrome	0.00117	0.0169	CbGeAlD
Triamcinolone—Sinus congestion—Metformin—polycystic ovary syndrome	0.00113	0.116	CcSEcCtD
Triamcinolone—NR3C1—female gonad—polycystic ovary syndrome	0.00113	0.0163	CbGeAlD
Triamcinolone—NR3C1—vagina—polycystic ovary syndrome	0.00112	0.0162	CbGeAlD
Triamcinolone—NR3C1—endocrine gland—polycystic ovary syndrome	0.00105	0.0152	CbGeAlD
Triamcinolone—PTGS2—adrenal gland—polycystic ovary syndrome	0.00105	0.0152	CbGeAlD
Triamcinolone—PTGS2—female gonad—polycystic ovary syndrome	0.000976	0.0141	CbGeAlD
Triamcinolone—PTGS2—vagina—polycystic ovary syndrome	0.00097	0.014	CbGeAlD
Triamcinolone—PTGS2—endocrine gland—polycystic ovary syndrome	0.000907	0.0131	CbGeAlD
Triamcinolone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000793	0.0115	CbGeAlD
Triamcinolone—Testolactone—CYP19A1—polycystic ovary syndrome	0.000572	0.0419	CrCbGaD
Triamcinolone—Neuropathy—Metformin—polycystic ovary syndrome	0.000527	0.0541	CcSEcCtD
Triamcinolone—Difluprednate—NR3C1—polycystic ovary syndrome	0.000478	0.035	CrCbGaD
Triamcinolone—Clocortolone—NR3C1—polycystic ovary syndrome	0.000463	0.034	CrCbGaD
Triamcinolone—Prednicarbate—NR3C1—polycystic ovary syndrome	0.000463	0.034	CrCbGaD
Triamcinolone—Injury—Metformin—polycystic ovary syndrome	0.000443	0.0455	CcSEcCtD
Triamcinolone—Desonide—NR3C1—polycystic ovary syndrome	0.000438	0.0321	CrCbGaD
Triamcinolone—Diflorasone—NR3C1—polycystic ovary syndrome	0.000438	0.0321	CrCbGaD
Triamcinolone—Desoximetasone—NR3C1—polycystic ovary syndrome	0.000427	0.0313	CrCbGaD
Triamcinolone—Loteprednol—NR3C1—polycystic ovary syndrome	0.000422	0.031	CrCbGaD
Triamcinolone—Fludrocortisone—AR—polycystic ovary syndrome	0.000416	0.0305	CrCbGaD
Triamcinolone—Fluoxymesterone—SHBG—polycystic ovary syndrome	0.000392	0.0288	CrCbGaD
Triamcinolone—Flumethasone Pivalate—NR3C1—polycystic ovary syndrome	0.000368	0.027	CrCbGaD
Triamcinolone—Halobetasol Propionate—NR3C1—polycystic ovary syndrome	0.000362	0.0265	CrCbGaD
Triamcinolone—Fluticasone Propionate—PGR—polycystic ovary syndrome	0.000357	0.0262	CrCbGaD
Triamcinolone—Abdominal distension—Metformin—polycystic ovary syndrome	0.000354	0.0364	CcSEcCtD
Triamcinolone—Influenza—Metformin—polycystic ovary syndrome	0.000352	0.0362	CcSEcCtD
Triamcinolone—Pancreatitis—Metformin—polycystic ovary syndrome	0.000345	0.0354	CcSEcCtD
Triamcinolone—Fluoxymesterone—AR—polycystic ovary syndrome	0.000344	0.0252	CrCbGaD
Triamcinolone—Sweating increased—Metformin—polycystic ovary syndrome	0.000343	0.0352	CcSEcCtD
Triamcinolone—Amcinonide—NR3C1—polycystic ovary syndrome	0.000336	0.0247	CrCbGaD
Triamcinolone—Budesonide—NR3C1—polycystic ovary syndrome	0.000336	0.0247	CrCbGaD
Triamcinolone—Fluticasone furoate—NR3C1—polycystic ovary syndrome	0.00033	0.0242	CrCbGaD
Triamcinolone—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000327	0.0336	CcSEcCtD
Triamcinolone—Betamethasone—PGR—polycystic ovary syndrome	0.000327	0.024	CrCbGaD
Triamcinolone—Mometasone—NR3C1—polycystic ovary syndrome	0.00032	0.0235	CrCbGaD
Triamcinolone—Rimexolone—NR3C1—polycystic ovary syndrome	0.000316	0.0232	CrCbGaD
Triamcinolone—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000308	0.0316	CcSEcCtD
Triamcinolone—Beclomethasone—NR3C1—polycystic ovary syndrome	0.000298	0.0219	CrCbGaD
Triamcinolone—Fluocinonide—NR3C1—polycystic ovary syndrome	0.000298	0.0219	CrCbGaD
Triamcinolone—Alclometasone—NR3C1—polycystic ovary syndrome	0.00029	0.0213	CrCbGaD
Triamcinolone—Fluocinolone Acetonide—NR3C1—polycystic ovary syndrome	0.00029	0.0213	CrCbGaD
Triamcinolone—Bradycardia—Metformin—polycystic ovary syndrome	0.000287	0.0295	CcSEcCtD
Triamcinolone—Rhinitis—Metformin—polycystic ovary syndrome	0.000282	0.029	CcSEcCtD
Triamcinolone—Fludrocortisone—NR3C1—polycystic ovary syndrome	0.000282	0.0207	CrCbGaD
Triamcinolone—Clobetasol propionate—NR3C1—polycystic ovary syndrome	0.000282	0.0207	CrCbGaD
Triamcinolone—Flunisolide—NR3C1—polycystic ovary syndrome	0.000282	0.0207	CrCbGaD
Triamcinolone—Paramethasone—NR3C1—polycystic ovary syndrome	0.000279	0.0204	CrCbGaD
Triamcinolone—Fluorometholone—NR3C1—polycystic ovary syndrome	0.000272	0.02	CrCbGaD
Triamcinolone—Methylprednisolone—NR3C1—polycystic ovary syndrome	0.000263	0.0193	CrCbGaD
Triamcinolone—Dexamethasone—CYP17A1—polycystic ovary syndrome	0.000256	0.0188	CrCbGaD
Triamcinolone—Clobetasol propionate—CYP1A1—polycystic ovary syndrome	0.000256	0.0188	CrCbGaD
Triamcinolone—Dexamethasone—CYP11A1—polycystic ovary syndrome	0.000252	0.0185	CrCbGaD
Triamcinolone—Erythema—Metformin—polycystic ovary syndrome	0.000245	0.0252	CcSEcCtD
Triamcinolone—Dysgeusia—Metformin—polycystic ovary syndrome	0.00024	0.0247	CcSEcCtD
Triamcinolone—Hydrocortisone—SHBG—polycystic ovary syndrome	0.000238	0.0175	CrCbGaD
Triamcinolone—Fluoxymesterone—NR3C1—polycystic ovary syndrome	0.000233	0.0171	CrCbGaD
Triamcinolone—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000228	0.0234	CcSEcCtD
Triamcinolone—Betamethasone—CYP19A1—polycystic ovary syndrome	0.000224	0.0164	CrCbGaD
Triamcinolone—Malaise—Metformin—polycystic ovary syndrome	0.000221	0.0227	CcSEcCtD
Triamcinolone—Syncope—Metformin—polycystic ovary syndrome	0.00022	0.0226	CcSEcCtD
Triamcinolone—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000216	0.0221	CcSEcCtD
Triamcinolone—Hypertension—Metformin—polycystic ovary syndrome	0.000212	0.0217	CcSEcCtD
Triamcinolone—Myalgia—Metformin—polycystic ovary syndrome	0.000209	0.0214	CcSEcCtD
Triamcinolone—Discomfort—Metformin—polycystic ovary syndrome	0.000206	0.0212	CcSEcCtD
Triamcinolone—BCHE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.000203	0.00227	CbGpPWpGaD
Triamcinolone—Prednisone—NR3C1—polycystic ovary syndrome	0.000201	0.0148	CrCbGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000201	0.00225	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.0002	0.00224	CbGpPWpGaD
Triamcinolone—Oedema—Metformin—polycystic ovary syndrome	0.0002	0.0206	CcSEcCtD
Triamcinolone—Infection—Metformin—polycystic ovary syndrome	0.000199	0.0204	CcSEcCtD
Triamcinolone—Fluticasone Propionate—NR3C1—polycystic ovary syndrome	0.000198	0.0145	CrCbGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—POMC—polycystic ovary syndrome	0.000197	0.00221	CbGpPWpGaD
Triamcinolone—Shock—Metformin—polycystic ovary syndrome	0.000197	0.0202	CcSEcCtD
Triamcinolone—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000193	0.0199	CcSEcCtD
Triamcinolone—NR3C1—Adipogenesis—NCOR1—polycystic ovary syndrome	0.000193	0.00216	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000193	0.00216	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000191	0.00214	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.000191	0.00213	CbGpPWpGaD
Triamcinolone—Dexamethasone—PGR—polycystic ovary syndrome	0.00019	0.0139	CrCbGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00019	0.00212	CbGpPWpGaD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000187	0.00209	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ADARB1—polycystic ovary syndrome	0.000186	0.00208	CbGpPWpGaD
Triamcinolone—Prednisolone—NR3C1—polycystic ovary syndrome	0.000185	0.0136	CrCbGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000183	0.00204	CbGpPWpGaD
Triamcinolone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000182	0.0187	CcSEcCtD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000182	0.00204	CbGpPWpGaD
Triamcinolone—Betamethasone—NR3C1—polycystic ovary syndrome	0.000182	0.0133	CrCbGaD
Triamcinolone—Paraesthesia—Metformin—polycystic ovary syndrome	0.00018	0.0185	CcSEcCtD
Triamcinolone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.000178	0.002	CbGpPWpGaD
Triamcinolone—Dyspnoea—Metformin—polycystic ovary syndrome	0.000178	0.0183	CcSEcCtD
Triamcinolone—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000178	0.00199	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.000177	0.00198	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000176	0.00197	CbGpPWpGaD
Triamcinolone—Dyspepsia—Metformin—polycystic ovary syndrome	0.000176	0.0181	CcSEcCtD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000174	0.00195	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000174	0.00195	CbGpPWpGaD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000174	0.00195	CbGpPWpGaD
Triamcinolone—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000173	0.00193	CbGpPWpGaD
Triamcinolone—Fatigue—Metformin—polycystic ovary syndrome	0.000173	0.0177	CcSEcCtD
Triamcinolone—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.000168	0.00188	CbGpPWpGaD
Triamcinolone—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000165	0.0169	CcSEcCtD
Triamcinolone—NR3C1—Adipogenesis—IRS2—polycystic ovary syndrome	0.000162	0.00182	CbGpPWpGaD
Triamcinolone—Urticaria—Metformin—polycystic ovary syndrome	0.000159	0.0163	CcSEcCtD
Triamcinolone—NR3C1—Adipogenesis—LEP—polycystic ovary syndrome	0.000159	0.00178	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000158	0.00177	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000158	0.00177	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000158	0.00177	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.000158	0.00177	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—DLG4—polycystic ovary syndrome	0.000154	0.00172	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000154	0.00172	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—LSM5—polycystic ovary syndrome	0.000151	0.00169	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000149	0.00167	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000148	0.00166	CbGpPWpGaD
Triamcinolone—Asthenia—Metformin—polycystic ovary syndrome	0.000144	0.0148	CcSEcCtD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000143	0.0016	CbGpPWpGaD
Triamcinolone—Hydrocortisone—NR3C1—polycystic ovary syndrome	0.000142	0.0104	CrCbGaD
Triamcinolone—NR3C1—Adipogenesis—IRS1—polycystic ovary syndrome	0.000142	0.00159	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.000142	0.00159	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000142	0.00158	CbGpPWpGaD
Triamcinolone—Pruritus—Metformin—polycystic ovary syndrome	0.000142	0.0145	CcSEcCtD
Triamcinolone—NR3C1—Gene Expression—SAP30L—polycystic ovary syndrome	0.000141	0.00157	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000141	0.00157	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00014	0.00156	CbGpPWpGaD
Triamcinolone—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000139	0.00156	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—PPARG—polycystic ovary syndrome	0.000138	0.00155	CbGpPWpGaD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000138	0.00154	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—INS—polycystic ovary syndrome	0.000136	0.00152	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000135	0.00151	CbGpPWpGaD
Triamcinolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000134	0.0015	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000133	0.00148	CbGpPWpGaD
Triamcinolone—Dizziness—Metformin—polycystic ovary syndrome	0.000132	0.0136	CcSEcCtD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000132	0.00148	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IGF1—polycystic ovary syndrome	0.000131	0.00147	CbGpPWpGaD
Triamcinolone—Dexamethasone—CYP19A1—polycystic ovary syndrome	0.00013	0.00956	CrCbGaD
Triamcinolone—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.00013	0.00146	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SUOX—polycystic ovary syndrome	0.00013	0.00145	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.00013	0.00145	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000129	0.00144	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000128	0.00143	CbGpPWpGaD
Triamcinolone—Vomiting—Metformin—polycystic ovary syndrome	0.000127	0.0131	CcSEcCtD
Triamcinolone—Rash—Metformin—polycystic ovary syndrome	0.000126	0.013	CcSEcCtD
Triamcinolone—Dermatitis—Metformin—polycystic ovary syndrome	0.000126	0.013	CcSEcCtD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000126	0.00141	CbGpPWpGaD
Triamcinolone—Headache—Metformin—polycystic ovary syndrome	0.000125	0.0129	CcSEcCtD
Triamcinolone—NR3C1—Adipogenesis—SERPINE1—polycystic ovary syndrome	0.000125	0.00139	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.000123	0.00138	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000123	0.00138	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.000121	0.00135	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00012	0.00134	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—TEAD2—polycystic ovary syndrome	0.00012	0.00134	CbGpPWpGaD
Triamcinolone—Nausea—Metformin—polycystic ovary syndrome	0.000119	0.0122	CcSEcCtD
Triamcinolone—NR3C1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000119	0.00133	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000118	0.00132	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000117	0.00131	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.000117	0.0013	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000113	0.00127	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000113	0.00126	CbGpPWpGaD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000111	0.00124	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00011	0.00123	CbGpPWpGaD
Triamcinolone—Dexamethasone—NR3C1—polycystic ovary syndrome	0.000106	0.00775	CrCbGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000105	0.00117	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000104	0.00117	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000104	0.00117	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000104	0.00116	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.000103	0.00115	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TEAD2—polycystic ovary syndrome	0.000103	0.00115	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000102	0.00114	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	9.89e-05	0.00111	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	9.86e-05	0.0011	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	9.76e-05	0.00109	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	9.74e-05	0.00109	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	9.7e-05	0.00109	CbGpPWpGaD
Triamcinolone—Dexamethasone—CYP1A1—polycystic ovary syndrome	9.6e-05	0.00704	CrCbGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	9.31e-05	0.00104	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	9.22e-05	0.00103	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	9.12e-05	0.00102	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	9.1e-05	0.00102	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	9.1e-05	0.00102	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	8.93e-05	0.000998	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	8.93e-05	0.000998	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	8.81e-05	0.000986	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	8.66e-05	0.000968	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	8.59e-05	0.000961	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	8.58e-05	0.000959	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	8.53e-05	0.000954	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	8.39e-05	0.000938	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	8.3e-05	0.000928	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	8.17e-05	0.000914	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	8.14e-05	0.000911	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	8.11e-05	0.000907	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	8.07e-05	0.000903	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	8.06e-05	0.000901	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—STAR—polycystic ovary syndrome	7.77e-05	0.000869	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	7.72e-05	0.000863	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.68e-05	0.000859	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	7.61e-05	0.000851	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	7.6e-05	0.000849	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	7.57e-05	0.000847	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	7.49e-05	0.000838	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	7.47e-05	0.000836	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	7.42e-05	0.000829	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	7.32e-05	0.000818	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	7.18e-05	0.000803	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	7.18e-05	0.000803	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	7.06e-05	0.000789	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	7.06e-05	0.000789	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	7.05e-05	0.000789	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HMMR—polycystic ovary syndrome	6.92e-05	0.000774	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	6.8e-05	0.000761	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	6.78e-05	0.000759	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	6.68e-05	0.000747	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	6.61e-05	0.000739	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.53e-05	0.00073	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	6.39e-05	0.000714	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.19e-05	0.000692	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	6.14e-05	0.000687	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LHB—polycystic ovary syndrome	6.02e-05	0.000674	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	6.01e-05	0.000672	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RPL37A—polycystic ovary syndrome	6e-05	0.000671	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	5.93e-05	0.000664	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	5.93e-05	0.000663	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	5.91e-05	0.000661	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	5.89e-05	0.000658	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	5.72e-05	0.00064	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	5.7e-05	0.000638	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HMMR—polycystic ovary syndrome	5.69e-05	0.000636	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	5.61e-05	0.000627	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—STAR—polycystic ovary syndrome	5.35e-05	0.000598	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5.29e-05	0.000591	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	5.25e-05	0.000587	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	5.13e-05	0.000574	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—RRM2—polycystic ovary syndrome	5.08e-05	0.000568	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	5.06e-05	0.000565	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	5.05e-05	0.000564	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	5e-05	0.000559	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—YAP1—polycystic ovary syndrome	4.9e-05	0.000548	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	4.86e-05	0.000543	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.85e-05	0.000542	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	4.78e-05	0.000534	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.78e-05	0.000534	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	4.77e-05	0.000533	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	4.71e-05	0.000526	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	4.69e-05	0.000524	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.68e-05	0.000523	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	4.65e-05	0.00052	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	4.64e-05	0.000519	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.62e-05	0.000516	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.55e-05	0.000509	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	4.55e-05	0.000508	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.49e-05	0.000503	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	4.39e-05	0.000491	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGF18—polycystic ovary syndrome	4.35e-05	0.000486	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	4.32e-05	0.000483	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RBP4—polycystic ovary syndrome	4.31e-05	0.000482	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	4.26e-05	0.000477	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.26e-05	0.000476	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LHB—polycystic ovary syndrome	4.15e-05	0.000464	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	4.05e-05	0.000453	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	3.99e-05	0.000446	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GAB1—polycystic ovary syndrome	3.97e-05	0.000444	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	3.97e-05	0.000443	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	3.92e-05	0.000439	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.9e-05	0.000436	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.9e-05	0.000436	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AR—polycystic ovary syndrome	3.89e-05	0.000435	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NAMPT—polycystic ovary syndrome	3.87e-05	0.000433	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	3.84e-05	0.000429	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TH—polycystic ovary syndrome	3.74e-05	0.000418	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	3.64e-05	0.000407	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.62e-05	0.000405	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.61e-05	0.000404	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	3.61e-05	0.000404	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	3.61e-05	0.000403	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	3.55e-05	0.000397	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	3.5e-05	0.000391	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	3.42e-05	0.000382	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	3.4e-05	0.00038	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	3.37e-05	0.000377	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	3.24e-05	0.000362	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.22e-05	0.00036	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	3.2e-05	0.000358	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.18e-05	0.000355	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	3.08e-05	0.000345	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	3.08e-05	0.000345	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GNAS—polycystic ovary syndrome	3.05e-05	0.000341	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	3.04e-05	0.00034	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	3.02e-05	0.000338	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	2.99e-05	0.000334	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	2.97e-05	0.000333	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	2.91e-05	0.000325	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRL—polycystic ovary syndrome	2.85e-05	0.000319	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	2.76e-05	0.000308	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.58e-05	0.000289	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TH—polycystic ovary syndrome	2.57e-05	0.000288	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	2.57e-05	0.000287	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	2.5e-05	0.00028	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.45e-05	0.000274	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	2.43e-05	0.000272	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NCOR1—polycystic ovary syndrome	2.39e-05	0.000267	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	2.35e-05	0.000263	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NRG1—polycystic ovary syndrome	2.35e-05	0.000262	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.34e-05	0.000261	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	2.19e-05	0.000245	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTHFR—polycystic ovary syndrome	2.11e-05	0.000236	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	2.1e-05	0.000235	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARG—polycystic ovary syndrome	2.08e-05	0.000233	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.08e-05	0.000233	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—POMC—polycystic ovary syndrome	2.06e-05	0.00023	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—INS—polycystic ovary syndrome	2.04e-05	0.000229	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IRS2—polycystic ovary syndrome	2.01e-05	0.000225	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	2e-05	0.000224	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.99e-05	0.000222	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	1.9e-05	0.000212	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.81e-05	0.000203	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.77e-05	0.000198	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	1.77e-05	0.000198	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IRS1—polycystic ovary syndrome	1.75e-05	0.000196	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.71e-05	0.000192	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—INS—polycystic ovary syndrome	1.68e-05	0.000188	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT2—polycystic ovary syndrome	1.62e-05	0.000182	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.58e-05	0.000176	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	1.54e-05	0.000173	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.53e-05	0.000171	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.47e-05	0.000165	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	1.43e-05	0.00016	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.41e-05	0.000158	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—POMC—polycystic ovary syndrome	1.41e-05	0.000158	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—INS—polycystic ovary syndrome	1.41e-05	0.000157	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.4e-05	0.000156	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.32e-05	0.000148	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.3e-05	0.000145	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.12e-05	0.000126	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.09e-05	0.000122	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.03e-05	0.000115	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	9.18e-06	0.000103	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	8.74e-06	9.78e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	8.29e-06	9.27e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	7.73e-06	8.64e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—polycystic ovary syndrome	7.34e-06	8.21e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	6.26e-06	7.01e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	6.18e-06	6.91e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	6.14e-06	6.87e-05	CbGpPWpGaD
